Madan Jagasia
Chief Executive Officer, Director · Obsidian Therapeutics, Inc.
Individual
- 2026
- Aug 5, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Madan Jagasia's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Brian Taylor Slingsby - $46.36M in MLYS purchases and sales in the last 12 months
- Matthew Gline - $46.17M in ROIV purchases and sales in the last 12 months
- Larry Robbins - $46.04M in BFLY purchases and sales in the last 12 months
- Michael John Kazley - $45.65M in SDEV purchases and sales in the last 12 months
- R01 Fund LP - $45.65M in SDEV purchases and sales in the last 12 months
- Neil Kumar - $45.20M in BBIO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Madan Jagasia?
Madan Jagasia is a corporate insider, tracked as Chief Executive Officer, Director of Obsidian Therapeutics, Inc. (OBX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Madan Jagasia submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.